TDRL-551
TDRL-551 is a potent replication protein A (RPA) inhibitor (IC50 = 18 µM) . TDRL-551 inhibits RPA-DNA interaction and increases the anti-cancer efficacy of Platinum (Pt) -based chemotherapy. TDRL-551 can be used for the research of cancer, such as non-small cell lung cancer (NSCLC) [1].
Product Specifications
CAS Number
1644626-43-6
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tdrl-551.html
Purity
99.84
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(CCCC(N1N=C(CC1C2=CC3=CC=C(C=C3N=C2Cl)OCC)C4=CC=C(C=C4)I)=O)O
Molecular Formula
C25H23ClIN3O4
Molecular Weight
591.83
References & Citations
[1]Mishra AK, et al. Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer. Biochem Pharmacol. 2015 Jan 1;93 (1) :25-33.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV775529 1.0 µg DNA
RPL7AP72 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
